(Q44585429)

English

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

scientific article published on 15 September 2003

In more languages
default for all languages
No label defined

No description defined

Statements

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study (English)
Gregory G Schwartz
William J Sasiela
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit